Equillium Inc

Equillium Inc is a clinical-stage biotechnology company focused on developing novel therapeutics. Its primary aim is to address severe immune-mediated and inflammatory disorders by targeting specific pathways. Headquartered in the US, the company aims to serve patients globally. Operating within the healthcare sector, Equillium Inc concentrates on developing innovative therapies for conditions like acute graft-versus-host disease and severe asthma. Its research intends to provide new treatment options to improve patient outcomes and quality of life. Track the share price of EQ by adding it to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.